Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
CT
Cytek Biosciences, Inc. Common Stock
CTKB
Mkt Cap
$683.1M
Volume
890.13K
Next Earnings
November 4th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
CT
CTKB
CT
Cytek Biosciences, Inc. Common Stock
CTKB
News
·
Cytek Biosciences to Unveil Next-Generation Spectral Flow Cytometry Innovations at CYTO 2026
Mkt Cap
$682.4M
Volume
890.13K
Next Earnings
November 4th
Chart
Financials
Earnings
News
About
Insider
Filings
Cytek Biosciences to Unveil Next-Generation Spectral Flow Cytometry Innovations at CYTO 2026
Cytek Biosciences unveiled its new 7-laser Cytek Borealis full spectrum flow cytometer featuring Deep Ultraviolet and Infrared capabilities with 120 detectors, enabling high-resolution 60-color panels. The company also announced automation-ready configurations for the Cytek Aurora Evo system designed to integrate with robotic plate handling and third-party scheduling platforms, targeting biopharma and CRO organizations.
GlobeNewswire Inc. · Jun 2, 2026
Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact
Cytek Biosciences marks the one-year anniversary of its 8,500-square-foot Singapore facility, which has enhanced manufacturing capacity, regional service capabilities, and supply chain resilience. The facility serves as a strategic hub for Asia-Pacific operations and supports the company's growth in cell analysis solutions driven by increasing global demand in immunology, immuno-oncology, and cancer research.
GlobeNewswire Inc. · Mar 9, 2026
Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results
Cytek Biosciences announced preliminary Q4 2025 revenue of approximately $62 million, representing 8% year-over-year growth and 19% sequential growth. Full year 2025 revenue is expected to be approximately $201 million. The company highlighted strong growth in Services, Reagents, and Asia Pacific instrument revenue, along with improved instrument sales in the US and EMEA regions, particularly a return to positive growth in EMEA.
GlobeNewswire Inc. · Jan 12, 2026
TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026
Cytek Biosciences was recognized by TIME and Statista as one of America's top-performing publicly listed companies, highlighting its exceptional growth, financial stability, and innovative cell analysis solutions.
GlobeNewswire Inc. · Nov 12, 2025
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year
Cytek Biosciences' Muse Micro cell analyzer won the 2025 BioTech Breakthrough Award for Drug Discovery Solution of the Year, highlighting its innovative approach to making cell analysis more accessible and cost-effective for laboratories.
GlobeNewswire Inc. · Nov 6, 2025
Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry
Cytek Biosciences is launching a two-part research support initiative to make cell analysis more accessible, including awarding a flow cytometer and planning a research grant program in collaboration with ISAC to support scientific research globally.
GlobeNewswire Inc. · Oct 29, 2025
Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth
Cytek Biosciences relocates and expands its European headquarters in Amsterdam, increasing its facility footprint by over 40% and establishing a dedicated customer service and training center to strengthen its presence in the EMEA region.
GlobeNewswire Inc. · Oct 15, 2025
Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA
Cytek Biosciences will showcase its advanced cell analysis solutions at ESCCA and ICCS conferences, highlighting its Full Spectrum Profiling technology and its potential to transform cell biology research through high-parameter spectral flow cytometry.
GlobeNewswire Inc. · Sep 10, 2025
Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change
MDxHealth appointed Michael Holder to its Board of Directors as Audit Committee Chair, replacing Regine Slagmulder. CFO Ron Kalfus is resigning, with Scott McMahan assuming interim CFO responsibilities.
GlobeNewswire Inc. · Jul 3, 2025
Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer
Cytek Biosciences has launched the Cytek Aurora™ Evo, a new full spectrum flow cytometer that improves on its flagship Cytek Aurora system. The new system offers high-throughput and automation capabilities to meet the demands of modern research.
GlobeNewswire Inc. · May 29, 2025
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
CT
CTKB
Cytek Biosciences, Inc. Common Stock
Buy
Sell
Market
Limit
Soon
CTKB
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any CTKB yet.
Related Tickers
Earnings